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Abstract
Amino acid replacements at dozens of positions in the dimeric protein human, Cu,Zn superoxide dismutase (SOD1) can
cause amyotrophic lateral sclerosis (ALS). Although it has long been hypothesized that these mutations might enhance the
populations of marginally-stable aggregation-prone species responsible for cellular toxicity, there has been little
quantitative evidence to support this notion. Perturbations of the folding free energy landscapes of metal-free versions of
five ALS-inducing variants, A4V, L38V, G93A, L106V and S134N SOD1, were determined with a global analysis of kinetic and
thermodynamic folding data for dimeric and stable monomeric versions of these variants. Utilizing this global analysis
approach, the perturbations on the global stability in response to mutation can be partitioned between the monomer
folding and association steps, and the effects of mutation on the populations of the folded and unfolded monomeric states
can be determined. The 2- to 10-fold increase in the population of the folded monomeric state for A4V, L38V and L106V and
the 80- to 480-fold increase in the population of the unfolded monomeric states for all but S134N would dramatically
increase their propensity for aggregation through high-order nucleation reactions. The wild-type-like populations of these
states for the metal-binding region S134N variant suggest that even wild-type SOD1 may also be prone to aggregation in
the absence of metals.
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Introduction
Amyotrophic lateral sclerosis is a devastating neurodegenerative
disease that affects 2 in every 100,000 people worldwide [1].
Approximately 10% of all ALS cases are inherited, i.e., familial
(fALS), of which 20% are caused by mutations in the SOD1 gene
that codes for the cytosolic enzyme Cu,Zn superoxide dismutase
(SOD1). SOD1 is a homo-dimeric protein, whose 153-residue
subunits fold into a b-barrel composed of eight anti-parallel b-
strands arranged in a Greek key motif [2]; short stretches of helix
form parts of the subunit interface and electrostatic loop (Figure 1).
The b-barrel structure of SOD1 provides the scaffold for the
electrostatic and Zn-binding loops [3]. Copper enables the redox
cycle responsible for the dismutation of superoxide anion to
molecular oxygen and hydrogen peroxide [4,5], and zinc stabilizes
the native dimeric conformation [6,7]. An intra-molecular
disulfide bond between Cys57 and Cys146 covalently links the
zinc-binding loop with the C-terminal b-strand, b8, and stabilizes
the native dimeric structure [8–10].
Over 140 point mutations dispersed throughout the sequence of
SOD1 (http://alsod.iop.kcl.ac.uk/Als/) can cause ALS by exert-
ing a gain-of-function toxicity [11]. Although a variety of
mechanisms for this toxicity have been proposed [1], the
appearance of SOD1-containing aggregates in neurons of patients
afflicted with ALS [12,13] is consistent with a possible role for
protein misfolding and aggregation in disease.
Controversy currently exists as to whether aggregation-prone
monomeric species, small oligomers or macroscopic aggregates are
the cytotoxic species [12,13]. Support for a crucial role for
monomeric SOD1 in aggregation is provided by the results of
studies in which SOD1 aggregates found in spinal cords extracted
from a human A4V SOD1 patient [14] and from various ALS
mouse models [14,15] reacted with antibodies specific for the
monomeric state [14]. Reduced monomeric apo-SOD1 has also
been implicated to initiate aggregation of dimeric holo-SOD1 at
neutral pH and 37uC [16], and disulfide-reduced SOD1 species are
enriched in the spinal cords of ALS mice [17]. Whichever species
proves to be the toxic agent, monomers of limited solubility would
likely play a central role in pathogenesis, either directly or as the
precursor to small oligomers or high-molecular-weight aggregates.
The misfolding and aggregation hypothesis has motivated a
variety of biophysical studies of the effects of the mutations on the
stability and folding mechanism of SOD1 [7,18–23]. All studies
conclude that a three-state mechanism, 2UO2MON2, provides
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an accurate description of the equilibrium mechanism for the
metal-free (apo) system. The U and N2 states represent the
unfolded monomeric and native dimeric forms of SOD1,respec-
tively, and M represents the folded monomeric form. In the
presence of zinc and/or copper, the same mechanism is operative.
The N2 and M states are both capable of binding metals at room
temperature, neutral pH and in the absence of denaturational
stress. By contrast, the U state has a greatly reduced affinity for
both metals under these conditions [6,7,24,25].
If the aggregation of the monomeric M or U species is involved
with toxicity in fALS, it might be expected that ALS-inducing
variants would enhance its population. With the exception of one
thermodynamic study that required the addition of stabilizing
agents to measure stabilities [22], previous folding studies of ALS
variants have not directly calculated populations. The goal of the
present study is to use a global kinetic analysis to quantitatively
assess the effects of ALS-inducing mutations on the populations of
the thermodynamic states in apo SOD1 that might be candidates
for aggregation.
To this end, perturbations of the folding free energy landscapes
of a set of five ALS-variants of SOD1 with survival times of less
than 3 years [26,27] were mapped; the wild-type-like variants [28],
A4V, L38V, G93A and L106V, and the metal-binding variant,
S134N. As shown in Figure 1, Ala4 is located in b1, adjacent to the
subunit interface, and the side chain points towards the interior of
the b-barrel. The side chains of Leu38 and Leu106 serve as
‘‘plugs’’ at the ends of the b-barrel and are located in the Greek
loops [2] that connect b3 and b4 (loop II) and b6 and b7 (loop VI),
respectively. Gly93 is located in loop IV that connects b5 and b6,
and it is proximal to Leu38. Along with Leu38, Gly93 takes part in
an extensive hydrogen-bond network between loop V and loop VI
that is thought to stabilize the b-barrel [8,29]. Ser134 participates
in a hydrogen-bonding network that bridges the electrostatic and
Zn binding loops and is largely exposed to solvent [8]. All of these
variants retain the dimeric quaternary structure of WT-SOD1
and, with the exception of S134N, effectively bind copper and zinc
ions. S134N is only partially-metallated when isolated from insect
cells [30] or yeast [31].
This present paper reports the population analysis for the
disulfide-containing apo-forms of these variants because they
provide a common reference state for both wild-type-like and
metal-binding variants and because apo-SOD1 is thought to be
involved in the formation of aggregates [16,32,33]. The results
provide the framework for a comprehensive quantitative analysis
of the effects of ALS mutations on the populations of monomeric
forms of SOD1 that may be responsible for aggregation.
Results
Mutagenesis
The A4V, L38V, G93A, L106V and S134N mutations were
introduced into the AS-SOD1 background [21], denoted herein as
WT, which contains the C6A/C111S mutations to eliminate
irreversible unfolding reactions caused by disulfide interchange
with the intra-subunit C57–C146 disulfide bond in the unfolded
state or by spontaneous oxidation of the cysteines by molecular
oxygen. The structure and the stability of disulfide-oxidized AS-
SOD1 are very similar to those for wild-type SOD1 [22,34].
Overall Strategy
The relative populations of the dimeric native state, N2, and the
monomeric states, M and U, for the ALS-variants were
determined by performing a comprehensive equilibrium and
kinetic analysis of their reversible urea-induced unfolding/
refolding reactions. The resultant perturbations of the maxima
and minima on the folding free energy surface, extrapolated to the
absence of denaturant, and the Bolzmann equation provide the
desired populations.
Equilibrium Analysis
To ascertain the effect of the five disease-causing mutations on
structure and thermodynamic stability, the equilibrium folding
properties of WT and the apo-forms of the five variants were
monitored by far-UV circular dichroism (CD) spectroscopy. The
CD spectra are largely super-imposable (Figure S1), demonstrating
that the secondary structures of these variants are not perturbed by
Figure 1. Ribbon diagram of human Cu,Zn superoxide dismutase. (left) The free cysteine residues at the sites of the C6A and C111S
mutations and the C57–C146 disulfide bond are shown in red and purple ball-and-stick models, respectively. The Zn-binding loop (loop IV; residues
49–82) is shown in pale blue, and the electrostatic loop (loop VII; residues 121–142) is in pale green. The Zn2+ and Cu2+ ions are shown as blue and
orange spheres, respectively. The sites of ALS mutations (A4V, L38V, G93A, L106V, and S134N) are highlighted in yellow ball-and-stick models. (right)
One monomer of SOD1 turned 90u around a horizontal axis toward the viewer. The figure was generated with PyMOL [52] using pdb code 2c9v [53].
doi:10.1371/journal.pone.0010064.g001
Monomer Populations in SOD1
PLoS ONE | www.plosone.org 2 April 2010 | Volume 5 | Issue 4 | e10064
the mutations. The mutations do, however, have a pronounced
effect on the apparent thermodynamic stability of all but the
S134N variant (Figure 2). The apparent stability was monitored by
reversible urea-induced equilibrium unfolding transitions for all
five variants at a series of different protein concentrations. As
expected for the dissociation and unfolding of a dimeric protein,
the midpoint of the unfolding transition, Cm, shifts to higher
denaturant concentration with increasing protein concentration
(Figure S2). The destabilizing effect of the mutations can be seen
by the dramatic shift in the midpoint of the transition Cm from
approximately 4 M urea for WT and S134N to below 2.5 M urea
for A4V, L38V, G93A and L106V at 10 mM protein.
The perturbation in stability induced by the mutations was
quantified by fitting the data to a 2-state dimer equilibrium
unfolding model, 2UON2 (Figure 2, Figure S2 and Table 1) [21].
As expected from the nearly coincident titration curves in Figure 2,
the stability, DGu, the denaturant dependence of the stability, the
m-value, and the Cm of S134N are within error of the values for
WT. The apparent stabilities of the other variants, however, are
significantly reduced: L38V and G93A are destabilized by
4 kcal mol21 compared to WT, while A4V and L106V are
further destabilized by approximately another 3 kcal mol21
(Table 1). The m-values, which often correlate with the change
in solvent accessible surface area accompanying unfolding [35],
vary from ,2.5 kcal mol21 M21 for the A4V variant to
,4.1 kcal mol21 M21 for the G93A variant. A variation in the
m-value of this magnitude is not expected for mutations that have
little effect on the secondary structure (Figure S1) and retain the
dimeric form. As will be shown below, a global kinetic analysis is
required to obtain accurate estimates of the relative stabilities of
the N2, M and U states for several of the SOD1 variants.
Kinetic Analysis
A more complete and accurate description of the perturbations
of the maxima and minima on the folding free energy surfaces for
the apo variants can be obtained by examination of the denaturant
dependence of the refolding and unfolding kinetics (chevron
analysis [36]). The advantage of this approach is that the
perturbations of the global stability can be partitioned into the
monomer folding step, UOM, and the association step, 2MON2.
This information is required to assess the effects of the mutations
on the relative populations of the M and U states.
The chevrons for the apo-ALS-variants have an overall urea
dependence that is similar to that for apo-WT [21] (Figure 3),
suggesting that the folding mechanism for the variants is consistent
with the three-state folding mechanism observed for WT,
2UO2MON2. The refolding relaxation times increase with
increasing denaturant concentrations up to a maximum value
near 2–2.5 M urea for A4V, L38V, G93A and L106V and near
4.0 M urea for S134N and WT. Above those urea concentrations,
where unfolding is favored, the relaxation times decrease in a non-
exponential fashion for WT and all variants except G93A. The
relaxation times for WT and the A4V, L38V, L106V and S134N
variants all roll-over to display a weak exponential dependence on
the urea concentration under strongly unfolding conditions. The
refolding relaxation times at 1 M urea vary by ,3-fold from WT,
while the unfolding relaxation times at 7 M urea vary ,70-fold,
from 13 s for L106V to 940 s for S134N.
The absence of a protein concentration dependence for
refolding under any conditions for all of the variants is consistent
with the rate-limiting unimolecular monomer folding reaction
observed for SOD1 [9,20,21]. A signature of this mechanism is the
appearance of protein concentration dependence in the unfolding
relaxation times in the transition zone from 2–6 M urea. All of the
variants show this behavior with the exception of the G93A
variant (Figure 3). This effect has been observed previously
[9,20,21] and reflects the increased apparent stability of the dimer
at higher protein concentrations relative to the rate-limiting
monomer unfolding transition state under these conditions. Under
strongly unfolding conditions, .6 M urea, the exponential
decrease in the relaxation time reflects the rate-limiting unim-
olecular dimer dissociation reaction [9,20,21].
Unlike for WT and all of the other variants, no change in the
urea dependence of the rate-limiting step in unfolding was
observed for G93A as the urea concentration was increased above
3 M. To test whether the unfolding, similar to WT, represents the
disappearance of dimeric G93A, the time-resolved fluorescence
(TR-FL) anisotropy decay of the intrinsic tryptophan was probed
during unfolding. The rotational correlation time measurements
demonstrated that the dimer, not the monomer, is present
immediately after unfolding to 3.5 and 7.0 M urea for G93A
(Figure S3 and Text S1). These results are consistent with the
entire unfolding leg of the G93A chevron reflecting the dimer
dissociation reaction, similar to the other variants and WT at high
urea concentrations. As will be shown in the global analysis below,
a faster monomer unfolding reaction and a slower dimer
dissociation reaction for G93A lead to the uncoupling of these
two reactions in the unfolding zone.
Determination of the folding reaction coordinate requires the
rate constants for each kinetic step in the absence of denaturant.
The rate constants for the first-order monomer folding reaction
and the dimer dissociation reaction can be obtained to a
reasonable degree of accuracy by linear extrapolation of the low
and high urea segments of the chevron to 0 M urea and the
relationship, k=1/t. However, these rate-limiting reactions in
folding and unfolding preclude the extraction of the monomer
unfolding rate constant and the association rate constant from the
chevron plot. Hence, and as was done for WT [21], a global
kinetic analysis of a comprehensive set of refolding and unfolding
CD traces for each variant was performed to determine the
microscopic rate constants for each step in the three-state folding
mechanism.
Figure 2. Normalized equilibrium unfolding transitions for
SOD1 variants. Data were measured by far-UV CD at 230 nm at
10 mM monomer concentration. (N) WT, (%) A4V, (m) L38V, (n) G93A,
(&) L106V, (#) S134N. Solid (for open symbols) and dashed (for closed
symbols) lines represent global fits of two to three protein concentra-
tions to a two-state model. The corresponding free energies are listed in
Table 1.
doi:10.1371/journal.pone.0010064.g002
Monomer Populations in SOD1
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Global Analysis
In the global analysis, the kinetic traces at a series of urea
concentrations ranging from 0.25 to 8.75 M urea and at several
protein concentrations ranging from 1 to 40 mM for each variant
were simultaneously fit to the three-state model, 2UO2MON2.
To obtain reliable and robust parameters for the kinetic
mechanism, it was necessary to fix the monomer unfolding rate
constant, ku and its associated m
{-value to those obtained from
stable monomeric variants of apo-AS-SOD1 (Figure 3). Other
than this modification, a detailed description of the fitting
procedure can be found elsewhere [21]. Kinetic traces with fits
obtained from the global analysis applied to each of the mutants
are shown in Figure S4.
The inverse of the microscopic rate constants predicted from the
fits as a function of the urea concentration for the variants are
projected on the chevrons in Figure 3, and the fit parameters are
presented in Table 1. As expected, the predicted relaxation times
for the monomer folding reaction, URM, at low denaturant
concentrations and the dimer dissociation reaction, N2R2M, at
high denaturant concentrations for these rate-limiting reactions
are in excellent agreement with the relaxation times extrapolated
from low and high urea concentrations, respectively. The global
analysis also reveals the predicted relaxation time for the
monomer-monomer association reaction, 2MRN2, across the
folding reaction coordinate from 0 to 8 M urea. The microscopic
rate constant for the monomer unfolding reactions in the absence
of urea, ku, extracted from the stable monomer variants varies 100-
fold, ranging from 2.061025 s21 for WT to 2.061023 s21 for
G93A (Figure 3 and Table 1). The association rate constants, ka,
vary ,12-fold, from 7.36104 M21 s21 for the L106V variant to
8.66105 M21 s21 for WT (Table 1).
It should be noted that the monomer unfolding rate constant, ku,
and the monomer association rate constant, ka, for WT shown in
Table 1 differ from the values previously reported using the global
analysis procedure [21]. In that prior analysis, ku and ka were
reported to be 9.4561024 s21 and 2.06109 M21s21, respectively.
The discrepancy reflects the existence of two minima on the chi-
square surface for the WT global fit; the second minimum was
only discovered by a reexamination motivated by the studies on
the variants, which exhibited a considerably reduced association
rate constant. The selection of the minimum with the significantly
reduced ka for WT was further confirmed by complementary
Fo¨rster resonance energy transfer studies directly probing the
association reaction (J.A.Z., O.B. and C.R.M., unpublished data).
The minimum reported in the present study also exhibits a
monomer unfolding rate for WT, A4V and L38V that is very
similar to that found for the stable monomer construct. Although
the monomer unfolding rate in the dimer context could not be
determined to the same degree of confidence for the remaining
variants by global analysis, the positive results for WT, A4V and
Table 1. Microscopic rate constants and kinetic m{-values obtained from the global kinetic analysis for WT SOD1 and the five ALS-
inducing variants.a
WT A4V L38V G93A L106V S134N
UOM
kf (7.9460.04)610
22 (16.360.2)61022 (3.3060.06)61022 (4.2260.07)61022 (2.3660.07)61022 (8.8660.38)61022
m{f 1.0760.01 1.0560.01 1.0260.01 0.9760.10 0.9460.02 1.0660.01
ku 0.20610
24 12.061024 3.061024 20.061024 6.0061024 0.1261024
m{u 20.59 20.61 20.80 20.64 20.67 20.65
DGu(U/M)
b,c 24.8260.12 22.8660.05 22.7460.14 21.7860.18 22.1460.20 25.1860.13
m(U/M)
d 1.6660.02 1.6660.02 1.8260.04 1.6160.05 1.6060.05 1.7060.02
2MON2
ka (0.8660.05)610
6 (0.1860.01)6106 (0.1260.02)6106 (0.3060.04)6106 (0.07360.016)6106 (0.2060.12)6106
m{a 0.3860.01 0.3860.11 0.4660.03 0.6060.03 0.5460.05 0.3660.07
kd (7.4560.27)610
24 (223612)61024 (5.5760.07)61024 (1.7860.02)61024 (15.160.6)61024 (2.2260.19)61024
m{d 20.0560.01 20.0860.01 20.2160.01 20.2660.01 20.3360.01 20.1360.01
DGu(2M/N2)
c 212.260.1 29.2660.03 211.260.1 212.460.1 210.360.13 212.060.4
m(2M/N2)
d 0.4260.01 0.4660.11 0.6860.03 0.8660.03 0.8760.05 0.5060.07
Kd 0.87 Nm 123 nM 4.6 nM 0.59 nM 21 nM 1.1 nM
2UO2MON2
DGu(2U/N2)
e 21.860.1 215.060.1 216.760.34 215.960.4 214.660.5 222.460.6
m(2U/N2)
f 3.7460.03 3.7960.04 4.3260.10 4.0860.14 4.0860.14 3.9160.10
DGu(H2O)eq 220.3761.04 211.5860.62 216.0360.95 215.7960.73 213.3360.54 219.7260.40
meq 3.3960.24 2.5360.26 4.0760.39 4.1160.30 3.4260.25 3.1760.10
aUnits for the UOM reaction: kf and ku, s21; m{f, m{u and m(U/M), kcal (molNmonomer)21 M21; DGu(U/M) kcal (molNmonomer)21. Units for the 2MON2 reaction: ka,
M21 s21; kd, s
21; m{a, m
{
d, and m(2M/N2), kcal (molNdimer)
21 M21; DGu(2M/N2) kcal (molNdimer)
21. Units for the complete 2UO2MON2 reaction: DGu(2U/N2) and
DGu(H2O)eq, kcal (molNdimer)
21; m(2U/N2) and meq, kcal (molNdimer)
21 M21.
bThe errors represent fitting errors with the monomer unfolding rate held fixed. True errors are estimated to be closer to 610%.
cCalculated according to DGu(U/M) =2RTlnK=2RTln(kf/ku) and DGu(2M/N2) =2RTlnK=2RTln(ka/kd).
dCalculated according to mtot = |m
{
u|+|m{f| for the monomer and mtot = |m{d|+|m{a| for the dimer.
eThe total free energy of folding was calculated as DGu(2U/N2) = 2 DGu(U/M)+DGu(2M/N2).
fCalculated as m(2U/N2) = 2(|m
{
f|)+|m{a|+2(|m{u|)+|m{d|.
doi:10.1371/journal.pone.0010064.t001
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L38V suggest that the chevron of the stable monomer construct is
a good approximation of the monomer chevron in the dimer.
Therefore, for consistency, in the present study the monomer
unfolding parameters were fixed to those experimentally measured
for the stable monomer variants, as described above. A similar
approach has previously been used by Oliveberg and his
colleagues in their studies on the folding of dimeric apo-AA-
SOD1 [9,20]. Although the presence of additional minima can
never be completely ruled out, a random sampling of the
parameter space consisting of at least 300 global fits was
performed for WT and all variants to minimize this possibility
and give added confidence that the parameters reported
correspond to the global minimum (Figure S5).
For each variant, these rate constants and their associated m{-
values can be used to calculate the free energies of the M state and
the N2 state relative to the U state across the entire range of urea
concentrations, recognizing that Kij = kij/kji and DGuij =2RT
lnKij. With the exception of the wild-type-like stability of the
S134N variant, DGu=222.4 kcal mol21, the standard state
stabilities of the N2 state relative to the U state for the remaining
variants are decreased by 6.8, 5.1, 5.9 and 7.2 kcal mol21 for the
A4V, L38V, G93A and L106V variants, respectively, relative to
the value for WT of 21.8 kcal mol21 (Table 1). These decreases in
stability are partitioned between the free energy changes for the
2UO2M and the 2MON2 steps in the three-state kinetic
mechanism (Figure 4). The stabilities of the M states for A4V,
L38V, G93A and L106V are decreased by 2.0, 2.1, 3.0 and
2.7 kcal mol21, respectively. With the exception of the small
increase of 0.2 kcal mol21 for the G93A variant, the reduction in
the free energy changes for the 2MON2 step for A4V, L38V and
L106V are 2.9, 1.0 and 1.9 kcal mol21, respectively. The
predicted Kd values for the dissociation of the dimer vary 200-
fold, ranging from 0.6 nM for G93A to 123 nM for A4V (Table 1).
Figure 3. Observed refolding and unfolding relaxation times plotted as a function of final urea concentration. Refolding (filled circles)
and unfolding (open circles) for WT, A4V, L38V, G93A, L106V, and S134N SOD1 were monitored by manual-mixing CD at 230 nm. The symbols
correspond to the different final protein concentrations; 1–2 mM (pink), 4 mM (blue), 10 mM (black), and 30 mM (red). Lines are the inverse of the
microscopic rate constants obtained in the global fits for the monomer refolding (solid green), monomer unfolding (dashed green), dimer association
(solid blue), and dimer dissociation reaction (dashed blue). For clarity, the dimer association reaction has been normalized to 10 mM protein
concentration. The relaxation times for the corresponding stable monomeric versions of these proteins are shown in grey circles, and the grey lines
represent fits of the data to a two-state kinetic model, UOM.
doi:10.1371/journal.pone.0010064.g003
Figure 4. Perturbations in free energies for the ALS-variants.
Perturbations relative to WT SOD1 were calculated from the parameters
obtained in the global kinetic analysis for each protein. The black bars
indicate the total change in free energy (2UON2); the white bars
indicate the change in free energy for the monomer (2UO2M), and the
grey bars indicate the change in free energy for the dimer association
reaction (2MON2).
doi:10.1371/journal.pone.0010064.g004
Monomer Populations in SOD1
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The free energy changes between states in the absence of urea,
along with their associated m-values, can be used to estimate the
relative populations of the N2, M and U states at equilibrium [21].
Potentially relevant to the misfolding/aggregation hypothesis for
toxicity in ALS, the relative populations of the M state for A4V
(7.6%), L38V (1.5%) and L106V (3.2%), increase by 2 to 12-fold
compared to WT (0.65%) at 10 mM protein concentration and in
the absence of denaturant (Figure 5A). However, the relative
population of the M states for G93A (0.54%) and S134N (0.74%)
are comparable to WT. By contrast, the U state shows a significant
enhancement in population for all of the ALS variants compared
to WT, with the exception of S134N. Although the relative
populations of the unfolded, U, state for A4V, L38V, G93A and
L106V are less than 0.1% at 10 mM protein, the populations only
differ by 6-fold from each other and are 80 to 480-fold higher than
for WT (Figure 5B). The population of U for S134N is comparable
to WT.
In addition to their populations at equilibrium, the populations
of N2, M and U can also be calculated as a function of refolding
time. The kinetic species plots derived from the global analysis
parameters in Table 1 are shown in Figure 6 for each of the
variants. Although modest enhancements of M are observed for
A4V, L38V and L106V compared to WT, the most striking
feature of these kinetic species plots is the remarkably long lifetime
of the U state (,10 s) for all of the variants. The U state of L38V,
G93A and L106V persists for even longer times than for WT
during refolding, while the lifetime of the U state is comparable for
S134N and slightly shorter for A4V. A time-resolved small angle x-
ray scattering study of WT showed that U undergoes very little
compaction under folding conditions [21].
Discussion
The global analysis of the kinetic folding data for apo-AS-SOD1
(WT) and five metal-free ALS-inducing variants, supported by the
kinetic folding data for monomeric versions of these variants, has
enabled the mapping of the perturbations of the maxima and
minima on the folding free energy surfaces resulting from
mutation. This strategy reveals the partitioning of the perturba-
tions in stability between the 2UO2M and the 2MON2 steps in
the three-state folding mechanism (Figure 4) and, thereby, the
effects of the ALS-variants on the relative populations of these
thermodynamic states at equilibrium (Figure 5) and during folding
(Figure 6). The increase in the population of the folded or unfolded
monomeric states is consistent with a role in initiating the
oligomerization and/or aggregation reactions that might be
responsible for toxicity in motor neurons (Figure 7).
The effects of ALS-causing variants on the free energy
landscape of SOD1 shown in Figure 7 suggest a potential
mechanism through which the ALS variants can oligomerize
and exert toxicity by either a significant destabilization of the
dimer, e.g., A4V, significant destabilization of the monomer, e.g.,
G93A, or a combination of both events, e.g., L38V and L106V.
The decreased global stability for the A4V, L38V and L106V
variants relative to WT is partitioned between the 2MON2 step
and the 2UO2M step in a way that leads to enhanced populations
of folded monomers (Figure 5A). For these variants, the decreased
association rate constants relative to WT suggest that the
mutations have a substantial effect on the population of the
association-competent fraction of the conformational ensemble
representing the M state [37]. The data imply a bias towards a
conformation of the monomer that may make it more likely to
misfold and form small oligomers (Figure 7). Consistent with this
idea, Akke and coworkers have recently used nuclear spin
relaxation dispersion experiments to identify a short-lived, weakly
populated monomeric conformation that could trigger oligomer-
ization of monomeric apo-AA-SOD1 [38].
The similar decreases in stability of the dimeric and monomeric
forms of G93A result in no change in the folded monomer
population compared to WT; however, G93A, as well as A4V,
L38V, and L106V show marked enhancement of the U state
compared to WT (Figure 5B). Although the fractions of the
unfolded states are small at equilibrium, ,0.1%, the dramatic
increase in the concentration, ,200-fold, would be magnified by
the order of the likely nucleation reaction, i.e., squared for second-
order, cubed for third-order, etc., suggesting that amorphous
aggregation of the U state may also play a role in toxicity (Figure 7).
Consistent with this observation, Marklund and coworkers have
shown that even small populations of misfolded mutant SOD1 can
cause ALS [39]. Additionally, the long lifetime of the U state (10’s
of seconds) during folding (Figure 6) could potentially enhance the
opportunities for U to participate in aberrant interactions.
The destabilizing effect of the mutations is not only limited to the
apo-dimer. Crow and co-workers have shown that A4V and L38V,
among other variants, destabilize metal binding as well [40]. Any
other interference with metal loading, such as oxidative damage of
SOD1 by superoxide, impaired zinc or copper homeostasis and
diminished copper loading by its chaperone, would shift the
equilibrium for SOD1 towards monomeric species [6,7,24]. For
Figure 5. Fractional populations of monomeric species. The
fractional populations of (A) the monomer and (B) the unfolded state at
equilibrium and 0 M urea for 0.1 mM (black), 1 mM (white) and 10 mM
(grey) protein concentration were calculated based on the parameters
from the global kinetic analysis (Table 1). The populations of the
unfolded states for WT SOD1 and S134N are multiplied by 10 in panel B
to make them visible.
doi:10.1371/journal.pone.0010064.g005
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example, the co-expression of WT human SOD1 in mice carrying
the A4V transgene exacerbates the toxicity of the A4V mutation
rather than relieving it [41]. If the WT protein, which has a higher
affinity for zinc than A4V [40], sequesters most of the available zinc,
the A4V SOD1 might well be zinc deficient and more aggregation-
prone than in the absence of the WT protein.
The toxicity of the S134N variant is intriguing in view of its
wild-type like folding reaction coordinate (Table 1 and Figure 7)
and population distribution (Figure 5). The results imply that for
this metal-deficient variant [42,43] and for metal-free WT SOD1,
even small populations of the M and U states may be sufficient to
cause aggregation and induce toxicity. Consistent with this
prediction are the results of a recent study in which disulfide-
reduced or unfolded WT SOD1 was found to be capable of
initiating the aggregation of disulfide-oxidized apo-protein as well
as zinc-bound protein [16].
A recent study by Prudencio et al. showed that ALS-inducing
SOD1 variants with a short disease duration had a high propensity
to aggregate in a cell culture model [44]. However, the
aggregation propensity of the more than 30 ALS-variants studied
did not correlate with any known biophysical property, including
global stability, net charge, or enzymatic activity. The enhanced
populations of unfolded monomeric forms for the ALS-variants of
SOD1 may provide the key. The high aggregation propensities of
A4V and G93A compared to the relatively low aggregation
propensity of S134N are consistent with the perturbations in the
population of unfolded monomeric forms observed in our study;
unfortunately, L38V and L106V were not tested in the study by
Prudencio et al. Although these aggregation-prone unfolded species
would be a logical target for chaperone-assisted folding and/or
proteosome degradation, the diminished potency of these
homeostasis mechanisms over time [45] could ultimately lead
afflicted neurons to succumb to cell death. Thus, the long-delayed
onset of familial ALS, ,45 years on average [26,27], might be
understood, in part, by the enhanced populations of monomeric
species in ALS variants (Figure 7).
Materials and Methods
Protein Purification
All materials and methods employed have previously been
described [21]. The ALS-inducing variants were introduced into the
pseudoWT C6A/C111S background to enhance reversibility of
folding [46], and the monomeric proteins also contained the F50E/
G51E mutations required to prevent dimerization [47,48].
Recombinant proteins were expressed in and purified from BL21-
Gold(DE3) PLysS cells (StratageneH, Inc. Cedar Creek, TX). When
required, the protein was purified twice over an anion exchange
QSepharose XL resin and/or by gel filtration using a Sephacryl
200HR column (GE Healthcare, Piscataway, NJ). Protein integrity
was assessed by measuring the molecular weight with LC-ESI mass
spectrometry. All experiments were performed using the apo form
of the proteins, which were prepared as described previously [21].
The protein concentrations were calculated using an extinction
coefficient of 10,800 M21 cm21 for the dimeric variants [49] and
5,400 M21 cm21 for the monomeric variants [21], and all protein
concentrations are given in monomer units. The standard buffer
used in all experiments was 10 mM potassium phosphate, 1 mM
K2EDTA, pH 7.2, and the temperature was 20uC.
Equilibrium and Kinetic Measurements
All equilibrium and kinetic measurements were performed on a
Jasco-810 spectropolarimeter as described previously [21]. For the
manual-mixing kinetic measurements, the signal change upon
refolding and unfolding was monitored at 230 nm, and the mixing
ratios varied from 1:3 to 1:28 depending on the final protein and
urea concentrations, which ranged from 1–30 mM protein and
0.4–7 M urea, respectively. All equilibrium and kinetic measure-
ments were analyzed according to published methods [21].
Global Analysis Methods
The raw unfolding and refolding kinetic traces at varying
protein and urea concentrations were globally fit to a 3-state
Figure 6. Kinetic species plots. Kinetic refolding species plots for U (solid line), M (dashed line) and N2 (dotted lines) were derived from the
parameters obtained in the global fit (Table 1). Protein concentrations are 0.1 mM (blue), 1 mM (green) and 10 mM (red).
doi:10.1371/journal.pone.0010064.g006
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kinetic mechanism, N2O2MO2U, using a Levenberg-Marquardt
non-linear least squares fitting algorithm in the in-house fitting
package Savuka, as described previously [21,50]. The concentra-
tions of all of the species were obtained by numerical solution of
the coupled kinetic rate equations given below using a Runge-
Kutta algorithm with an adaptive step size:
1
2
dU(t)
dt
~{k
0
f U(t)zk
0
uM(t)
1
2
dM(t)
dt
~{kaM
2(t){k
0
uM(t)zk
0
f U(t)zkdN(t)
dN(t)
dt
~{kdN(t)zkaM
2(t)
where U(t), M(t) and N(t) are the concentrations of the unfolded
state, folded monomeric state and dimeric native state at time t,
respectively. The rates k’f, k’u, ka and kd are the monomer folding,
unfolding, association and dimer dissociation rates, respectively.
The rates k’f and k’u for the monomer folding reaction above
(2UO2M) are related to those reported in Table 1 for the UOM
folding reaction by multiplying by 2, i.e., kf = 2k’f and ku = 2k’u. The
rate constant at any given urea concentration, kxy, was expressed in
terms of the rate in the absence of urea, kuxy, and the m- value:
kxy~k
o
xy . e
{mxy½urea=RT
The equilibrium free-energy at standard state conditions, i.e. in the
absence of urea and 1 M reactants and products, between species x
and y is obtained as:
DGoxy~{RT ln
koxy
koyx
 !
This gives the free-energy in the monomer reference state for the U
to M folding reaction and the free-energy in the dimer reference
state for the 2M to N2 folding reaction. The free-energy for the U to
M folding reaction needs to be multiplied by a factor of 2 to obtain
the free-energy in the dimer reference state:
DGo,dimeric~2DGo,mono
Because free-energy is an extensive property, the free energy is
reported in the dimer reference state. For computational efficiency,
kinetic traces comprising ,1000 points were logarithmically
averaged to yield ,100 points evenly spaced in log-time and then
fit simultaneously using an iterative procedure as previously
described [21,50]. Adjustable global, i.e. linked, parameters in the
optimization consisted of the microscopic rate constants, koxy, the
kinetic m values, mxy, the Z-values, a normalized measure of the
extent to which the intermediate resembles the unfolded state,
Z~ YI{YN2
 .
YU{YN2
 
, and the native and unfolded state
baselines. The Z-values for all of the variants are close to zero,
consistent with the similar CD spectra for the monomeric and
dimeric variants [51]. The N2 and M species are discriminated
kinetically by the change in the nature of the rate-limiting step in the
transition region. The protein concentration was allowed to vary by
up to 10% to account for the accuracy of the concentration
measurement by absorbance.
Each optimization began by solving for the equilibrium
concentration of all species under the starting conditions and then
correcting for the dilution ratio. Although the starting conditions
were, to a good approximation, fully native dimer or fully unfolded
monomer, this approach was used to increase the generality of the
kinetic model and to insure that the numerical algorithm could
accommodate all starting conditions with equal accuracy. The
initial concentrations were obtained from the following equations
with the rates corresponding to the rates under the initial
conditions instead of the final conditions:
0~{k
0
f U(t)zk
0
uM(t)
0~{kaM
2(t){k
0
uM(t)zk
0
f U(t)zkdN(t)
0~{kdN(t)zkaM
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Figure 7. Effect of ALS-causing variants on the free energy
landscape of SOD1. The folding reaction coordinates at 10 mM
protein under native conditions are calculated from the global fits
based on the results of in vitro kinetic measurements. The Tanford b
value is used as the order parameter and is calculated from the kinetic
m-values in Table 1 according to b=mf/(mf2mu). This order parameter
is expected to be proportional to solvent accessible surface area. The
black line represents the folding reaction coordinate of the WT protein,
which is nearly coincident with the reaction coordinate for the S134N
variant (not shown). Other disease mutations result in selective
destabilization of the dimer and/or significant destabilization of the
monomer. The A4V variant (blue) predominately affects the dimer
stability, whereas the G93A variant (red) has the largest effect on the
monomer stability. The L38V (green) and L106V (not shown) variants
affect both steps. Based on the enhanced populations of partially-
folded forms observed for the ALS-causing variants, aggregation (red
arrows) is hypothesized to proceed from the monomer (M) or unfolded
(U) species. The wild-type like reaction coordinate observed for the
metal-deficient S134N suggests that even WT SOD can aggregate in the
absence of metals. Although the reaction coordinate shown is semi-
quantitative, one caveat to including both monomers and dimers i a
single reaction coordinate is that it is necessary to plot them with
respect to different reference states. The part of the reaction coordinate
corresponding to the monomer reaction is, therefore, scaled with
respect to a monomer reference state and the bimolecular step is
scaled with respect to a dimer reference state. A prefactor of 16109 s21
and 16109 M21s21 was used for the unimolecular and bimolecular
steps, respectively, in relating the rate to an activation free-energy
using Kramers theory.
doi:10.1371/journal.pone.0010064.g007
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This iterative procedure was repeated until the kinetic parameters
were optimized to yield the best fit. The goodness of fit was
evaluated by the randomness of the residuals and the reduced-x2.
Supporting Information
Text S1 Time-resolved Fluorescence (TR-FL) Anisotropy Ex-
perimental Methods.
Found at: doi:10.1371/journal.pone.0010064.s001 (0.03 MB
DOC)
Figure S1 Circular dichroism spectra of apo-AS-SOD1 and the
metal-free ALS-causing variants show well-folded global struc-
tures. Solid lines denote CD spectra at a protein concentration of
10 uM in 10 mM potassium phosphate, pH 7.2, 1 mM EDTA,
20 C: WT (black), A4V (red), L38V (green), G93A (pink), L106V
(blue), and S134N (olive). The dashed line indicates the unfolded
spectrum of WT in 7 M urea; the unfolded spectra of all of the
ALS-causing variants are coincident with the WT spectrum.
Found at: doi:10.1371/journal.pone.0010064.s002 (0.50 MB TIF)
Figure S2 Equilibrium unfolding traces monitored by CD at
230 nm for ALS variants. Protein concentrations are ((open
circles) 4 uM, (closed circles) 10 uM, and (open squares) 30 uM
monomer)) for (A) WT, (B) A4V, (C) L38V, (D) G93A, (E) L106V,
and (F) S134N. The lines are from a global fit of 4–6 singular value
decomposition vectors for each variants as described in Svensson
et al. [1] (solid line, 4 uM; dashed line 10 uM; dotted line 30 uM).
Found at: doi:10.1371/journal.pone.0010064.s003 (2.06 MB TIF)
Figure S3 Time-resolved fluorescence anisotropy of G93A. The
colored lines depict the anisotropy decay at various unfolding
timepoints in (A) 3.5 M and (B) 7 M urea. (A,B) light blue - 0 s,
pink - 270 s, green - 570 s, yellow - 1170 s, and red - 1770 s. (C)
The 0 s time point anisotropy decay for G93A at 3.5 M (light blue)
and 7 M (blue) urea are compared to the equilibrium anisotropy
decays of native (orange) and unfolded (3.5 M - hatched red line;
7 M - hatched black line) G93A and to those for native AS-SOD1
(black) and mAS-SOD1 (grey) [1]. The close agreement between
the decays for dimeric WT and G93A SOD1 demonstrates that a
dimer is the initial species in the unfolding reaction. The protein
concentration was 10 uM monomer for all measurements.
Found at: doi:10.1371/journal.pone.0010064.s004 (3.94 MB TIF)
Figure S4 Representative kinetic refolding and unfolding traces
for WT and the five ALS-inducing SOD1 variants. The global fit
using the model N2to2Mto2U is overlaid on the log-sampled data
for each data set. The final urea concentration of each trace is
color coded according to the color bar to the right of each panel.
For WT, 29 unfolding traces at a protein concentration of 5 and
15 uM and 23 refolding traces at 5 and 15 uM are shown. For
A4V, 16 representative refolding traces ranging from 4 to 20 uM
protein concentration and 16 representative unfolding traces
ranging from 2 to 10 uM protein concentration are shown. For
L38V, 16 representative refolding traces at 10 uM protein
concentration and 13 representative unfolding traces at 6 uM
and 11.7 uM are shown. For G93A, 9 refolding traces at 10 uM
final protein concentration and 14 representative unfolding traces
spanning the 7.5 uM to 30 uM protein concentration range are
shown. For L106V, 18 refolding traces at 3 and 9 uM protein
concentration and 18 unfolding traces ranging from 4 to 30 8 uM
protein concentration are shown. For S134N, 6 representative
refolding traces at 10 uM protein concentration and 17 unfolding
traces at 10 and 20 uM are shown.
Found at: doi:10.1371/journal.pone.0010064.s005 (8.16 MB TIF)
Figure S5 Rigorous error analysis for the association rate, ka, for
WT, S134N and G93A SOD1 variants. The WT chi-square error
surface (top) is representative of a case where the association rate is
well determined. The S134N variant (middle) displays the worst-
case scenario, a situation where the upper bound on the
association rate could not be determined with the same degree
of confidence as for the wild-type protein. A typical case is
represented by the G93A variant (bottom), where the upper and
lower bounds given by the 68% confidence interval are well
defined. The 68% confidence level was calculated based on an F-
test. The error analysis was done by starting several hundred
global fits from pseudo-random starting parameters with the
association rate fixed to the value indicated by the x-coordinate of
each point on the plot. The solid line outlining the minimum is
drawn to aid the eye.
Found at: doi:10.1371/journal.pone.0010064.s006 (0.99 MB TIF)
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